Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2‐mediated direct suppression and M1/M3‐mediated indirect suppression through endocannabinoid signalling
- 18 May 2004
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 19 (10) , 2682-2692
- https://doi.org/10.1111/j.0953-816x.2004.03384.x
Abstract
The cholinergic system in the CNS plays important roles in higher brain functions, primarily through muscarinic acetylcholine receptors. At cellular levels, muscarinic activation produces various effects including modulation of synaptic transmission. Here we report that muscarinic activation suppresses hippocampal inhibitory transmission through two distinct mechanisms, namely a cannabinoid‐dependent and cannabinoid‐independent mechanism. We made paired whole‐cell recordings from cultured hippocampal neurons of rats and mice, and monitored inhibitory postsynaptic currents (IPSCs). When cannabinoid receptor type 1 (CB1) was blocked, oxotremorine M (oxo‐M), a muscarinic agonist, suppressed IPSCs in a subset of neuron pairs. This suppression was associated with an increase in paired‐pulse ratio, blocked by the M2‐prefering antagonist gallamine, and was totally absent in neuron pairs from M2‐knockout mice. When CB1 receptors were not blocked, oxo‐M suppressed IPSCs in a gallamine‐resistant manner in cannabinoid‐sensitive pairs. This suppression was associated with an increase in paired‐pulse ratio, blocked by the CB1 antagonist AM281, and was completely eliminated in neuron pairs from M1/M3‐compound‐knockout mice. Our immunohistochemical examination showed that M2 and CB1 receptors were present at inhibitory presynaptic terminals of mostly different origins. These results indicate that two distinct mechanisms mediate the muscarinic suppression. In a subset of synapses, activation of M2 receptors at presynaptic terminals suppresses GABA release directly. In contrast, in a different subset of synapses, activation of M1/M3 receptors causes endocannabinoid production and subsequent suppression of GABA release by activating presynaptic CB1 receptors. Thus, the muscarinic system can influence hippocampal functions by controlling different subsets of inhibitory synapses through the two distinct mechanisms.Keywords
This publication has 55 references indexed in Scilit:
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- Retrograde signaling at central synapses via endogenous cannabinoidsMolecular Psychiatry, 2002
- Pharmacological modulation of GABAA receptor‐mediated postsynaptic potentials in the CA1 region of the rat hippocampusBritish Journal of Pharmacology, 1998
- A characterization of muscarinic receptor‐mediated intracellular Ca2+ mobilization in cultured rat hippocampal neuronesThe Journal of Physiology, 1998
- Molecular Biology of Muscarinic Acetylcholine ReceptorsCritical Reviews™ in Neurobiology, 1996
- Differential effects of kindling and kindled seizures on place learning in the morris water mazeHippocampus, 1993
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluRl, in transfected CHO cellsNeuron, 1992
- The septo-hippocampal projection: a model cholinergic pathwayTrends in Neurosciences, 1985